Zhujiang Hospital
Clinical trials sponsored by Zhujiang Hospital, explained in plain language.
-
ICU dialysis: which dose of blood thinner works best?
Disease control Recruiting nowThis study compares two starting doses (20 mg/h vs. 50 mg/h) of the blood thinner nafamostat in ICU patients receiving continuous kidney dialysis. The goal is to see which dose keeps the dialysis filter working longer without causing bleeding. About 92 adults with normal clotting…
Phase: PHASE2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated May 26, 2026 09:33 UTC
-
New hope for leukemia patients: drug may ease Post-Transplant anemia
Disease control Recruiting nowThis study tests a drug called luspatercept in 46 people with acute leukemia who have anemia after a stem cell transplant. The goal is to see if it safely raises hemoglobin levels and reduces the need for blood transfusions. Participants get two shots of the drug in the first mon…
Phase: PHASE1, PHASE2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated May 26, 2026 09:26 UTC
-
New drug cocktail aims to stop leukemia relapse after transplant
Disease control Recruiting nowThis study is for people with high-risk acute myeloid leukemia (AML) who have had a stem cell transplant. Researchers want to see if giving two drugs, azacitidine and chidamide, after the transplant can help prevent the leukemia from coming back. The study will also check how saf…
Phase: PHASE1, PHASE2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
New combo therapy aims to stop liver cancer recurrence in High-Risk patients
Disease control Recruiting nowThis study tests whether combining a liver-directed procedure (TACE) with the drug icaritin can help prevent liver cancer from returning after surgery in patients at high risk of recurrence. About 30 adults who recently had their liver cancer completely removed will receive this …
Phase: PHASE2, PHASE3 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Gut bacteria boosts lung cancer treatment in new trial
Disease control Recruiting nowThis study tests whether a daily probiotic called LR607 can make standard chemo-immunotherapy more effective for people with stage IIB-IIIB non-small cell lung cancer that can be surgically removed. About 46 adults will take the probiotic for 3 months alongside their treatment. T…
Phase: PHASE2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
AI takes on kidney biopsies: could it match the experts?
Diagnosis Recruiting nowThis study is testing an artificial intelligence (AI) system that reads kidney biopsy images to help diagnose chronic kidney disease. Researchers will compare the AI's results to the standard diagnosis made by pathologists. The goal is to see how accurate the AI is at identifying…
Sponsor: Zhujiang Hospital • Aim: Diagnosis
Last updated May 18, 2026 11:58 UTC
-
New sedative could shorten time on ventilators for ICU patients
Symptom relief Recruiting nowThis study compares two sedatives, remimazolam and midazolam, in 440 critically ill adults on breathing machines in the ICU. The goal is to see if remimazolam helps patients come off the ventilator faster. Participants will be randomly assigned to receive one of the two drugs, an…
Phase: NA • Sponsor: Zhujiang Hospital • Aim: Symptom relief
Last updated May 26, 2026 09:30 UTC
-
Zap to awaken: new brain stimulation trial hopes to spark awareness
Symptom relief Recruiting nowThis study tests a new, non-invasive brain stimulation method called theta-burst patterned temporal interference stimulation (tTIs) to see if it can improve awareness in people with disorders of consciousness, like vegetative or minimally conscious states. About 136 participants …
Phase: NA • Sponsor: Zhujiang Hospital • Aim: Symptom relief
Last updated May 26, 2026 09:22 UTC
-
Ear zaps might wake up brain injury patients
Symptom relief Recruiting nowThis study tests a safe, non-invasive technique called transcutaneous auricular vagus nerve stimulation (taVNS) in 20 people with disorders of consciousness after severe brain injury. Participants receive two 20-minute ear stimulation sessions daily for 10 days. The goal is to se…
Phase: NA • Sponsor: Zhujiang Hospital • Aim: Symptom relief
Last updated May 20, 2026 11:53 UTC
-
Mouth bacteria may predict cancer treatment success
Knowledge-focused Recruiting nowThis study looks at how the bacteria in the mouth change in 32 people with advanced oral cancer after they receive chemotherapy combined with immunotherapy. Researchers want to see if these bacterial changes are linked to how well the tumor shrinks and to long-term survival. The …
Sponsor: Zhujiang Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC
-
Blood test may spot liver cancer return months before scans
Knowledge-focused Recruiting nowThis study looks at whether a simple blood test can predict if liver cancer will return after surgery. Researchers will track tiny bits of tumor DNA in the blood over time. The goal is to see if this test can find signs of cancer earlier than standard imaging. About 255 adults wi…
Sponsor: Zhujiang Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:52 UTC